Sarah A M Cuddy1,2, Melissa L Coyle1,3, Rodney H Falk1,4. 1. Brigham and Women's Hospital Amyloidosis Program, Boston, Massachusetts. 2. Nuclear Medicine Department, Brigham and Women's Hospital, Boston, Massachusetts. 3. Partners Healthcare Specialty Pharmacy, Burlington, Massachusetts. 4. Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.
Authors: Maxwell Birger; Alexander S Kaldjian; Gregory A Roth; Andrew E Moran; Joseph L Dieleman; Brandon K Bellows Journal: Circulation Date: 2021-04-30 Impact factor: 39.918